Literature DB >> 21716315

A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis.

K Vandenbroeck1, J Alvarez, B Swaminathan, I Alloza, F Matesanz, E Urcelay, M Comabella, A Alcina, M Fedetz, M A Ortiz, G Izquierdo, O Fernandez, N Rodriguez-Ezpeleta, C Matute, S Caillier, R Arroyo, X Montalban, J R Oksenberg, A Antigüedad, A Aransay.   

Abstract

Cytokine and cytokine receptor genes, including IL2RA, IL7R and IL12A, are known risk factors for multiple sclerosis (MS). Excitotoxic oligodendroglial death mediated by glutamate receptors contributes to demyelinating reactions. In the present study, we screened 368 single-nucleotide polymorphisms (SNPs) in 55 genes or gene clusters coding for cytokines, cytokine receptors, suppressors of cytokine signaling (SOCS), complement factors and glutamate receptors for association with MS in a Spanish-Basque resident population. Top-scoring SNPs were found within or nearby the genes coding for SOCS-1 (P=0.0005), interleukin-28 receptor, alpha chain (P=0.0008), oncostatin M receptor (P=0.002) and interleukin-22 receptor, alpha 2 (IL22RA2; P=0.003). The SOCS1 rs243324 variant was validated as risk factor for MS in a separate cohort of 3919 MS patients and 4003 controls (combined Cochran-Mantel-Haenszel P=0.00006; odds ratio (OR)=1.13; 95% confidence interval (CI)=1.07-1.20). In addition, the T allele of rs243324 was consistently increased in relapsing-remitting/secondary progressive versus primary-progressive MS patients, in each of the six data sets used in this study (P(CMH)=0.0096; OR=1.24; 95% CI 1.05-1.46). The association with SOCS1 appears independent from the chr16MS risk locus CLEC16A.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716315     DOI: 10.1038/gene.2011.44

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  32 in total

Review 1.  Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.

Authors:  Yudong Liu; Sara A Gibson; Etty N Benveniste; Hongwei Qin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

Review 2.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

Review 3.  Toll-Like Receptor Pathways in Autoimmune Diseases.

Authors:  Ji-Qing Chen; Peter Szodoray; Margit Zeher
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

4.  CpG Island Methylation Patterns in Relapsing-Remitting Multiple Sclerosis.

Authors:  Maria Sokratous; Efthimios Dardiotis; Eleni Bellou; Zisis Tsouris; Amalia Michalopoulou; Maria Dardioti; Vasileios Siokas; Dimitrios Rikos; Aristidis Tsatsakis; Leda Kovatsi; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou
Journal:  J Mol Neurosci       Date:  2018-03-07       Impact factor: 3.444

5.  Genetic contribution of suppressor of cytokine signalling polymorphisms to the susceptibility to infection after traumatic injury.

Authors:  A Zhang; W Gu; H Lu; L Zeng; L Zhang; D Du; J Hao; D Wen; X Wang; J Jiang
Journal:  Clin Exp Immunol       Date:  2018-09-09       Impact factor: 4.330

6.  The roles of Egr-2 in autoimmune diseases.

Authors:  Min Zhang; Ying Wang; Jian-Shu Wang; Jiao Liu; Meng-Meng Liu; Hai-Bing Yang
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 7.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 8.  Emerging role of interleukin-22 in autoimmune diseases.

Authors:  Hai-Feng Pan; Xiang-Pei Li; Song Guo Zheng; Dong-Qing Ye
Journal:  Cytokine Growth Factor Rev       Date:  2012-08-18       Impact factor: 7.638

Review 9.  Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.

Authors:  Etty N Benveniste; Yudong Liu; Braden C McFarland; Hongwei Qin
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

10.  Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.

Authors:  Sarah M McCormick; Nagaraj Gowda; Jessie X Fang; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.